Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luc Chouinard

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Toxicologic Pathology|May 10, 2008
Neurotoxic effects of zoniporide: a selective inhibitor of the NA+/H+ exchanger isoform 1John C Pettersen, Luc Chouinard, Roy L Kerlin, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 23, 2011
Rat-specific decreases in platelet count caused by a humanized monoclonal antibody against sclerostinDaniel G Rudmann, Todd J Page, John L Vahle, et al.
Regulatory Toxicology and Pharmacology : RTP|August 30, 2016
Carcinogenicity risk assessment of romosozumab: A review of scientific weight-of-evidence and findings in a rat lifetime pharmacology studyLuc Chouinard, Melanie Felx, Nacera Mellal, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Toxicologic Pathology|May 10, 2008
Neurotoxic effects of zoniporide: a selective inhibitor of the NA+/H+ exchanger isoform 1John C Pettersen, Luc Chouinard, Roy L Kerlin, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 23, 2011
Rat-specific decreases in platelet count caused by a humanized monoclonal antibody against sclerostinDaniel G Rudmann, Todd J Page, John L Vahle, et al.
Regulatory Toxicology and Pharmacology : RTP|August 30, 2016
Carcinogenicity risk assessment of romosozumab: A review of scientific weight-of-evidence and findings in a rat lifetime pharmacology studyLuc Chouinard, Melanie Felx, Nacera Mellal, et al.
Pageof 3